Before revision: Hydroxychloroquine or chloroquine antiparasitic and antirheumatic; generic made by many manufacturersmalaria, rheumatoid arthritis, lupus (International) CEPI, WHO, INSERM Multiple sites in China; global Solidarity and Discovery Trials June 2020 (discontinued by WHO)multiple side effects; possible adverse prescription drug interactions; discontinued in June from WHO Solidarity trial and UK Recovery trial as "having no clinical benefit in hospitalised patients with COVID-19"; trialsFavipiravir antiviral against influenza influenza (China)Fujifilm China April 2020 Lopinavir/ritonavir without or with interferon beta-1a antiviral, immune suppression investigational combination; lopinavir/ritonavir approved CEPI, WHO, UK Government, Univ.
After revision: for HIVHydroxychloroquine or chloroquine antiparasitic and antirheumatic; generic made by many manufacturersmalaria, rheumatoid arthritis, lupus (International) CEPI, WHO, INSERM Multiple sites in China; global Solidarity and Discovery Trials June 2020 (discontinued by WHO)multiple side effects; possible adverse prescription drug interactions; discontinued in June from WHO Solidarity trial and UK Recovery trial as "having no clinical benefit in hospitalised patients with COVID-19"; trialsFavipiravir antiviral against influenza influenza (China)Fujifilm China April 2020 Lopinavir/ritonavir without or with interferon beta-1a antiviral, immune suppression investigational combination; lopinavir/ritonavir approved CEPI, WHO, UK Government, Univ.